ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
SerpinA3 is an Endogenous TGF-β Receptor Antagonist that Attenuates Cardiac Fibroblast Activation and Fibrotic Remodeling.
Hui Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.